Acquisition synergies Potential cross-sell opportunities with Broncus Holding Corp portfolio leveraging Uptake Medical’s vapor technology assets for bronchoscopic ablation and lung disease treatment in hospitals and clinics that already work with Broncus.

Small firm agility Target mid to large hospital systems and specialty centers seeking innovative endoscopic solutions for emphysema and lung disorders, emphasizing rapid deployment, cost efficiency, and minimal invasive approaches.

Technology focus Position offerings around integration with existing device ecosystems and compatibility with current procedural workflows, highlighting non-foreign-material approaches that appeal to value-based care models.

R&D and funding Explore partnerships or licensing with institutions pursuing cutting-edge vapor-based lung therapies, leveraging the company’s proven Vapor technology for co-development and grant-enabled pilots.

Geographic leverage Leverage Seattle-based roots and Broncus network to access West Coast and broader U.S. markets with targeted pilots, physician evangelists, and KOLs to accelerate adoption of endoscopic lung interventions.